Researchers have looked into how far away the Voyager spacecraft could go while we could still detect them, and worked out ...

VY1706, an IV-delivered tau silencing gene therapy that has shown up to 73% knockdown of tau mRNA in non-human primates following a single IV dose and is advancing towards IND in 2026.

The Voyager spacecraft, Voyager 1 and 2, have traveled farther than any human-made objects in history, entering interstellar ...

Voyager 1, Earth’s farthest spacecraft, has been on an extraordinary journey for over 45 years, exploring uncharted ...

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager's wholly- ...

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...

U.S. companies dominated the investment landscape, capturing 70% of global spacetech funding in Q2, or roughly $2.2 billion.

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Boeing, now more than $2 billion in the hole to pay for all Starliner's delays, is still more than a year away from executing ...

Review Voyager Technologies Inc Class A (VOYG:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Scientists have found that Uranus is emitting its own internal heat — even more than it receives from sunlight — and this ...

Secondary marketplace for private securities EquityZen is out with a note on Q2 activity. The company stated that Circle's successful initial public offering ...